1. Home
  2. LNN vs SPRY Comparison

LNN vs SPRY Comparison

Compare LNN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNN
  • SPRY
  • Stock Information
  • Founded
  • LNN 1954
  • SPRY 2015
  • Country
  • LNN United States
  • SPRY United States
  • Employees
  • LNN N/A
  • SPRY N/A
  • Industry
  • LNN Industrial Machinery/Components
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNN Industrials
  • SPRY Health Care
  • Exchange
  • LNN Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • LNN 1.5B
  • SPRY 1.2B
  • IPO Year
  • LNN 1988
  • SPRY N/A
  • Fundamental
  • Price
  • LNN $124.06
  • SPRY $14.88
  • Analyst Decision
  • LNN Hold
  • SPRY Strong Buy
  • Analyst Count
  • LNN 1
  • SPRY 4
  • Target Price
  • LNN $128.00
  • SPRY $28.75
  • AVG Volume (30 Days)
  • LNN 114.0K
  • SPRY 2.2M
  • Earning Date
  • LNN 04-03-2025
  • SPRY 05-08-2025
  • Dividend Yield
  • LNN 1.16%
  • SPRY N/A
  • EPS Growth
  • LNN 12.44
  • SPRY N/A
  • EPS
  • LNN 7.03
  • SPRY 0.08
  • Revenue
  • LNN $647,542,000.00
  • SPRY $89,149,000.00
  • Revenue This Year
  • LNN $11.29
  • SPRY $1.49
  • Revenue Next Year
  • LNN $3.37
  • SPRY $141.68
  • P/E Ratio
  • LNN $17.65
  • SPRY $186.00
  • Revenue Growth
  • LNN 0.46
  • SPRY 297063.34
  • 52 Week Low
  • LNN $109.27
  • SPRY $7.55
  • 52 Week High
  • LNN $140.26
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • LNN 45.62
  • SPRY 66.37
  • Support Level
  • LNN $114.81
  • SPRY $11.80
  • Resistance Level
  • LNN $129.26
  • SPRY $15.12
  • Average True Range (ATR)
  • LNN 5.61
  • SPRY 1.04
  • MACD
  • LNN 0.20
  • SPRY 0.20
  • Stochastic Oscillator
  • LNN 46.04
  • SPRY 92.77

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: